Transplant Genomics Publications
Publications are listed by date
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.
Stuart M. Flechner (1), Sunil M. Kurian (2), Kim Solez (3), Daniel J. Cook (1), James T. Burke (4), Hank Rollin (1), Jennifer A. Hammond (5), Thomas Whisenant (5), Caroline M. Lanigan (5), Steven R. Head (5), and Daniel R. Salomon (2)
(1) Section of Renal Transplantation, Transplant Center, Allogen Laboratories, The Cleveland Clinic Foundation, (2) Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, (3) Department of Pathology, University of Alberta, Edmonton, Alberta, Canada, (4) Immunology/Clinical Sciences, Wyeth Laboratories, Paris, France, (5) DNA Array Core Facility, The Scripps Research Institute, La Jolla, California
see supplemental data for this publication
-
Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes.
Stuart M. Flechner (1), Sunil M. Kurian (2), Steven R. Head (3), Starlette M. Sharp (2), Thomas C. Whisenant (3), Jie Zhang (4), Jeffrey D. Chismar (3), Steve Horvath (5), Tony Mondala (3), Timothy Gilmartin (3), Daniel J. Cook (1), Steven A. Kay (4), John R. Walker (4) and Daniel R. Salomon (2)
(1) Section of Renal Transplantation, Transplant Center A110, Cleveland Clinic Foundation, Cleveland, OH, (2) Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, (3) DNA Array Core Facility, The Scripps Research Institute, La Jolla, CA, (4) The Genomics Institute of the Novartis Research Foundation, San Diego, CA, (5) Departments of Human Genetics and Biostatistics, David Geffen School of Medicine, University of California, LA, CA
see supplemental data for this publication
